News

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
TOLE2 FOS study patient recruitment expected to complete in the next few months with topline data anticipated in early 2026 ...
The Manila Times15h
Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress
Data presentation included efficacy and biomarker analyses from the NAVIGATE trial (n=287). Belapectin 2 mg/kg demonstrated a statistically significant reduction in new varices at 18 months in the per ...
AES Corp. stock outperforms competitors on strong trading day
Shares of AES Corp. AES rallied 5.05% to $10.82 Thursday, on what proved to be an all-around great trading session for the ...
Zacks Investment Research on MSN5d
Why AES (AES) is a Top Momentum Stock for the Long-Term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Chancery Court Dismisses Challenge to a Del. Corporation’s Advance Notice Bylaws for Lack of Ripeness Following 'Kellner'
The bylaws, adopted in 2023 following the SEC’s universal proxy rule, imposed enhanced disclosure obligations on nominating ...